May 9, 2013

The Life Sciences Report:

Six Superstars for Your Biotech Portfolio

by : Tracy Salcedo

The Life Sciences Report: The consensus is that biotech is on the upswing and that it may be a safer bet for investors than gold or energy at this point in time. Do you agree? Can you tell me why?

John McCamant: The numbers are big, in that biotech was the number one performing sector in 2012. It is up again this year. People are a little nervous about that, but the numbers don’t lie.

What does that tell us? We’ve come a long way in the cycle, so biotech companies are much more mature. We have a better idea of what are better targets. There have been some significant advances.  …read more